VivoSim Labs (VIVS) Gross Profit (2011 - 2026)
VivoSim Labs (VIVS) posted quarterly Gross Profit of $40000.0 for Q1 2026, down 21.57% year-over-year from $51000.0 in Q1 2025, and up 53.85% quarter-over-quarter from $26000.0 in Q4 2025.
VivoSim Labs (VIVS) Gross Profit (2011 - 2026) Analysis & Trends
VivoSim Labs' Gross Profit history runs 10 years deep, the most recent figure standing at $40000.0 for Q1 2026.
- In Q1 2026, Gross Profit fell 21.57% year-over-year to $40000.0; the TTM figure through Mar 2026 stood at $131000.0 (down 5.76% YoY), while the FY2026 annual figure was $131000.0, down 5.76% from the prior year.
- Gross Profit for Q1 2026 stood at $40000.0, up from $26000.0 in the prior quarter.
- The five-year high for Gross Profit was $75000.0 in Q2 2023, with the low at $5000.0 in Q4 2023.
- The 4-year median for Gross Profit is $29000.0 (2024), against an average of $34454.5.
- Peak annual rise in Gross Profit reached 340.0% in 2024, while the deepest fall reached 50.67% in 2024.
- VivoSim Labs' Gross Profit stood at $5000.0 in 2023, then soared by 340.0% to $22000.0 in 2024, then grew by 18.18% to $26000.0 in 2025, then soared by 53.85% to $40000.0 in 2026.
- Business Quant data shows VIVS's Gross Profit at $40000.0 in Q1 2026, $26000.0 in Q4 2025, and $28000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | VivoSim Labs | 1.49 Mn | 1.49 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40,000.00 |
| Mar 31, 2026 | 40,000.00 |
| Dec 31, 2025 | 26,000.00 |
| Dec 31, 2025 | 26,000.00 |
| Sep 30, 2025 | 28,000.00 |
| Sep 30, 2025 | 28,000.00 |
| Jun 30, 2025 | 37,000.00 |
| Jun 30, 2025 | 37,000.00 |
| Mar 31, 2025 | 51,000.00 |
| Mar 31, 2025 | 51,000.00 |
| Dec 31, 2024 | 22,000.00 |
| Dec 31, 2024 | 22,000.00 |
| Sep 30, 2024 | 29,000.00 |
| Sep 30, 2024 | 29,000.00 |
| Jun 30, 2024 | 37,000.00 |
| Jun 30, 2024 | 37,000.00 |
| Mar 31, 2024 | 29,000.00 |
| Mar 31, 2024 | 29,000.00 |
| Dec 31, 2023 | 5,000.00 |
| Dec 31, 2023 | 5,000.00 |